{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Noonan syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_selumetinib",
          "name": "Selumetinib"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ribociclib",
          "name": "Ribociclib"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_everolimus",
          "name": "Everolimus"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_trametinib",
          "name": "Trametinib"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_sirolimus",
          "name": "Sirolimus"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_dabrafenib",
          "name": "Dabrafenib"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_lenvatinib",
          "name": "Lenvatinib"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_bosutinib",
          "name": "Bosutinib"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_azacitidine",
          "name": "Azacitidine"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_vemurafenib",
          "name": "Vemurafenib"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_nilotinib",
          "name": "Nilotinib"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_imatinib",
          "name": "Imatinib"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 3
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_selumetinib",
          "type": "Drug",
          "label": "Selumetinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ribociclib",
          "type": "Drug",
          "label": "Ribociclib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_everolimus",
          "type": "Drug",
          "label": "Everolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_trametinib",
          "type": "Drug",
          "label": "Trametinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dabrafenib",
          "type": "Drug",
          "label": "Dabrafenib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lenvatinib",
          "type": "Drug",
          "label": "Lenvatinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_bosutinib",
          "type": "Drug",
          "label": "Bosutinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azacitidine",
          "type": "Drug",
          "label": "Azacitidine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_vemurafenib",
          "type": "Drug",
          "label": "Vemurafenib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_nilotinib",
          "type": "Drug",
          "label": "Nilotinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_imatinib",
          "type": "Drug",
          "label": "Imatinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_MAPK",
          "type": "Target",
          "label": "MAPK",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_MAPK_pathway",
          "type": "Pathway",
          "label": "MAPK signaling pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_Noonan_syndrome",
          "type": "Disease",
          "label": "Noonan syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_selumetinib",
          "target": "target_MAPK",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知机制作用于MAPK通路"
        },
        {
          "source": "drug_ribociclib",
          "target": "target_MAPK",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与MAPK通路有关的药理"
        },
        {
          "source": "drug_everolimus",
          "target": "target_MAPK",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "影响细胞增殖相关通路"
        },
        {
          "source": "drug_trametinib",
          "target": "target_MAPK",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "直接抑制MAPK/ERK信号通路"
        },
        {
          "source": "drug_sirolimus",
          "target": "target_MAPK",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通路交互作用"
        },
        {
          "source": "drug_lenvatinib",
          "target": "target_MAPK",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "靶向受体酪氨酸激酶相关"
        },
        {
          "source": "target_MAPK",
          "target": "pathway_MAPK_pathway",
          "relation": "involved_in",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "通路重要成分"
        },
        {
          "source": "pathway_MAPK_pathway",
          "target": "disease_Noonan_syndrome",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与Noonan症候群的结合关系"
        },
        {
          "source": "drug_selumetinib",
          "target": "H1",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "支持药物作用假设"
        },
        {
          "source": "drug_ribociclib",
          "target": "H2",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "支持药物作用假设"
        },
        {
          "source": "drug_everolimus",
          "target": "H3",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "支持药物作用假设"
        },
        {
          "source": "drug_trametinib",
          "target": "H4",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "支持药物作用假设"
        },
        {
          "source": "drug_sirolimus",
          "target": "H5",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "支持药物作用假设"
        },
        {
          "source": "drug_dabrafenib",
          "target": "H6",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "支持药物作用假设"
        },
        {
          "source": "drug_lenvatinib",
          "target": "H7",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "支持药物作用假设"
        },
        {
          "source": "drug_bosutinib",
          "target": "H8",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "支持药物作用假设"
        },
        {
          "source": "drug_azacitidine",
          "target": "H9",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "支持药物作用假设"
        },
        {
          "source": "drug_vemurafenib",
          "target": "H10",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "支持药物作用假设"
        },
        {
          "source": "drug_nilotinib",
          "target": "H11",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "支持药物作用假设"
        },
        {
          "source": "drug_imatinib",
          "target": "H12",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "支持药物作用假设"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物影响MAPK通路可能对Noonan症候群产生治疗效果",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "药物具备到达靶器官的足够暴露（基于药理学常识）"
    ],
    "uncertainties": [
      "药物长期使用安全性及有效性需进一步验证"
    ],
    "next_focus_for_pi": [
      "评估是否需要对其他靶点或通路进行补充研究"
    ]
  }
}